State Street Corp Mesoblast LTD Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.94 - $4.18 $676,200 - $961,399	230,000 New	230,000 $756,000
Q3 2021 Nov 15, 2021	SELL	$5.87 - $7.85 $528,300 - $706,500	-90,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.69 - $9.0 $602,100 - $810,000	90,000 New	90,000 $673,000
Q1 2021 May 17, 2021	SELL	$8.26 - $11.4 $454,300 - $627,000	-55,000 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$11.33 - $19.81 $113,016 - $197,604	9,975 Added 22.15%	55,000 $1.02 Million
Q2 2020 Aug 14, 2020	BUY	$4.2 - $15.45 $189,105 - $695,636	45,025 New	45,025 $513,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.